KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dillard'S (DDS) Gains from Investment Securities (2019 - 2025)

Dillard'S (DDS) has disclosed Gains from Investment Securities for 10 consecutive years, with -$878000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 104.66% year-over-year to -$878000.0, compared with a TTM value of -$4.6 million through Nov 2025, down 19.62%, and an annual FY2025 reading of -$1.6 million, up 68.45% over the prior year.
  • Gains from Investment Securities was -$878000.0 for Q4 2025 at Dillard'S, down from -$13000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $5.1 million in Q1 2022 and bottomed at -$4.9 million in Q1 2024.
  • Average Gains from Investment Securities over 5 years is $25600.0, with a median of -$183500.0 recorded in 2022.
  • The sharpest move saw Gains from Investment Securities plummeted 2517.86% in 2021, then surged 304.25% in 2023.
  • Year by year, Gains from Investment Securities stood at $3.4 million in 2021, then plummeted by 110.32% to -$354000.0 in 2022, then crashed by 525.71% to -$2.2 million in 2023, then skyrocketed by 80.63% to -$429000.0 in 2024, then crashed by 104.66% to -$878000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for DDS at -$878000.0 in Q4 2025, -$13000.0 in Q3 2025, and -$1.1 million in Q2 2025.